Jesus Rodriguez-Pascual, Gema Hernández, Lisardo Ugidos, Alejandro Parralejo, Juan Diego Rodriguez-Castaño, Juan Jose Serrano, Angel Ayuso. "Durvalumab (DUR) effectiveness in advanced biliary tract cancer (aBTC) patients based on real-world data evidence.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.4_suppl.598